Thomas Fehr

9.6k total citations · 2 hit papers
148 papers, 6.3k citations indexed

About

Thomas Fehr is a scholar working on Transplantation, Immunology and Surgery. According to data from OpenAlex, Thomas Fehr has authored 148 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Transplantation, 41 papers in Immunology and 31 papers in Surgery. Recurrent topics in Thomas Fehr's work include Renal Transplantation Outcomes and Treatments (42 papers), T-cell and B-cell Immunology (23 papers) and Immune Cell Function and Interaction (22 papers). Thomas Fehr is often cited by papers focused on Renal Transplantation Outcomes and Treatments (42 papers), T-cell and B-cell Immunology (23 papers) and Immune Cell Function and Interaction (22 papers). Thomas Fehr collaborates with scholars based in Switzerland, United States and Germany. Thomas Fehr's co-authors include Rolf M. Zinkernagel, Peter Ammann, Hans Rickli, Hans Hengartner, Adrian F. Ochsenbein, Rudolf P. Wüthrich, Micha T. Maeder, Megan Sykes, Martin F. Bachmann and Frank Brombacher and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Thomas Fehr

143 papers receiving 6.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Control of Early Viral and Bacterial Distribution and Disease by Natural Antibodies

1999 734 citations Thomas Fehr, Rolf M. Zinkernagel et al. profile →
Immunodeficiency and Chronic Myelogenous Leukemia-like Syndrome in Mice with a Targeted Mutation of the ICSBP Gene

1996 547 citations Jürgen Löhler, Yuka Kanno et al. Cell profile →

Peers

Countries citing papers authored by Thomas Fehr

Since Specialization

Citations

This map shows the geographic impact of Thomas Fehr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Fehr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Fehr more than expected).

Fields of papers citing papers by Thomas Fehr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Fehr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Fehr. The network helps show where Thomas Fehr may publish in the future.

Co-authorship network of co-authors of Thomas Fehr

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Fehr. A scholar is included among the top collaborators of Thomas Fehr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Fehr. Thomas Fehr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Stillbirth and fulminant postpartum haemolysis: COVID-19 or leptospirosis or both? 2023 ·BMJ Case Reports ·(unknown), Thomas Fehr, (unknown), (unknown)	1
2	Impact of the COVID-19 pandemic on emergency outpatient consultations and admissions of non-COVID-19 patients (ECCO)—A cross-sectional study 2022 ·PLoS ONE ·(unknown), Stefania Di Gangi, (unknown), Oliver Senn, (unknown), Thomas Fehr	6
3	Long-term survival after heart transplantation 2017 ·Cardiovascular Medicine ·(unknown), Luca Mazzucchelli, (unknown), Thomas Fehr, Augusto Gallino	0
4	Effect of Twice-Yearly Denosumab on Prevention of Bone Mineral Density Loss in De Novo Kidney Transplant Recipients: A Randomized Controlled Trial 2015 ·American Journal of Transplantation ·Marco Bonani, Diana Frey, Jens Brockmann, Thomas Fehr, Thomas Mueller, Lanja Saleh, Arnold von Eckardstein, Norbert Graf, Rudolf P. Wüthrich	68
5	Absence of donor CD40 protects renal allograft epithelium and preserves renal function 2013 ·Transplant International ·(unknown), Pietro E. Cippà, Ariana Gaspert, Jin Chen, Ilka Edenhofer, R. Wüthrich, Maja T. Lindenmeyer, Stephan Segerer, Thomas Fehr	7
6	Allospecific Rejection of MHC Class I-Deficient Bone Marrow by CD8 T Cells 2013 ·American Journal of Transplantation ·Fabienne Haspot, Raymond Li, C. Lucas, Thomas Fehr, Semir Beyaz, Megan Sykes	5
7	Antibody-mediated kidney allograft rejection: therapeutic options and their experimental rationale 2012 ·Transplant International ·Thomas Fehr, Ariana Gaspert	51
8	The BH3-mimetic ABT-737 inhibits allogeneic immune responses 2011 ·Transplant International ·Pietro E. Cippà, (unknown), Ilka Edenhofer, Stephan Segerer, Jin Chen, Martin Hausmann, Yang Liu, Annick Guimezanes, Philip D. Bardwell, Rudolf P. Wüthrich, Thomas Fehr	12
9	Elevated Cardiac Troponin I in Sepsis and Septic Shock: No Evidence for Thrombus Associated Myocardial Necrosis 2010 ·PLoS ONE ·David Altmann, Wolfgang Korte, Micha T. Maeder, Thomas Fehr, Philipp K. Haager, Hans Rickli, Gian‐Reto Kleger, Regulo Rodriguez, Peter Ammann	54
10	Chronic Norovirus Infection after Kidney Transplantation: Molecular Evidence for Immune‐Driven Viral Evolution 2010 ·Clinical Infectious Diseases ·(unknown), Marina Höhne, Astrid Meerbach, Walter Bossart, Rudolf P. Wüthrich, E. Schreier, N Müller, Thomas Fehr	117
11	A novel risk assessment tool for rejection and infection to individually tailor immunosuppression in renal transplantation 2009 ·Lund University Publications (Lund University) ·Thomas Fehr, Henrik Ekberg, Teun van Gelder, Corrado Bernasconi, (unknown), Marc Schiesser	1
12	Rapid Deletional Peripheral CD8 T Cell Tolerance Induced by Allogeneic Bone Marrow: Role of Donor Class II MHC and B Cells 2008 ·The Journal of Immunology ·Thomas Fehr, Sophia Y. Wang, Fabienne Haspot, Josef Kurtz, Peter Blaha, (unknown), Meredith Chittenden, Thomas Wekerle, Megan Sykes	27
13	Alloreactive CD8 T Cell Tolerance Requires Recipient B Cells, Dendritic Cells, and MHC Class II 2008 ·The Journal of Immunology ·Thomas Fehr, Fabienne Haspot, (unknown), Meredith Chittenden, (unknown), Megan Sykes	28
14	Influence of drugs and comorbidity on serum potassium in 15 000 consecutive hospital admissions 2008 ·Nephrology Dialysis Transplantation ·Samuel Henz, Micha T. Maeder, Silke Huber, Maurizio Schmid, (unknown), Thomas Fehr	23
15	Measurement of PTH Fragments for Assessment of Renal Bone Disease in Hemodialysis Patients 2006 ·Kidney & Blood Pressure Research ·Thomas Fehr, Daniela Garzoni, (unknown), Isabelle Binet, Rudolf P. Wüthrich	3
16	Sepsis-Associated Myocardial Dysfunction 2006 ·CHEST Journal ·Micha T. Maeder, Thomas Fehr, Hans Rickli, Peter Ammann	234
17	Statin-induced immunomodulatory effects on human T cells in vivo 2004 ·Atherosclerosis ·Thomas Fehr, Christian R. Kahlert, Walter Fierz, Helen I. Joller‐Jemelka, Walter F. Riesen, Hans Rickli, Rudolf P. Wüthrich, Peter Ammann	88
18	Troponin as a risk factor for mortality in critically ill patients without acute coronary syndromes 2003 ·Journal of the American College of Cardiology ·Peter Ammann, Marco Maggiorini, Osmund Bertel, (unknown), Helen I. Joller‐Jemelka, Erwin Oechslin, Elisabeth I. Minder, Hans Rickli, Thomas Fehr	278
19	Correlation of anti-viral B cell responses and splenic morphology with expression of B cell-specific molecules 2000 ·International Immunology ·Thomas Fehr	17
20	Immunodeficiency and Chronic Myelogenous Leukemia-like Syndrome in Mice with a Targeted Mutation of the ICSBP Gene breakdown → 1996 ·Cell ·(unknown), Jürgen Löhler, Yuka Kanno, Thomas Fehr, Nathalia A. Giese, Frank Rosenbauer, (unknown), Klaus‐Peter Knobeloch, Lucia Gabriele, Jeffrey F. Waring, Martin F. Bachmann, Rolf M. Zinkernagel, Herbert C. Morse, Keiko Ozato, Ivan D. Horak	547

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact